This page lists the SEC filings reported by Forbion Capital Fund III Cooperatief U.A..
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-02-14 | Forbion Capital Fund III Cooperatief U.A. | enGene Holdings Inc. | 3,369,275 | 14.2% | EDGAR |
| SC 13G/A | 2024-02-14 | Forbion Capital Fund III Cooperatief U.A. | Replimune Group, Inc. | 5,191,621 | 8.7% | EDGAR |
| SC 13G | 2023-11-13 | Forbion Capital Fund III Cooperatief U.A. | enGene Holdings Inc. | 3,369,811 | 14.2% | EDGAR |
| SC 13G/A | 2021-02-16 | Forbion Capital Fund III Cooperatief U.A. | Milestone Pharmaceuticals Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2021-02-16 | Forbion Capital Fund III Cooperatief U.A. | Replimune Group, Inc. | 5,115,121 | 11.1% | EDGAR |
| SC 13G/A | 2020-02-11 | Forbion Capital Fund III Cooperatief U.A. | Replimune Group, Inc. | 5,115,121 | 14.4% | EDGAR |
| SC 13G | 2020-02-11 | Forbion Capital Fund III Cooperatief U.A. | Milestone Pharmaceuticals Inc. | 1,303,902 | 5.3% | EDGAR |
| SC 13G | 2019-02-14 | Forbion Capital Fund III Cooperatief U.A. | Replimune Group, Inc. | 4,970,121 | 15.8% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.